Schedule 13G ownership disclosure

DiaMedica Therapeutics Inc

Voting Common Shares, no par value · CUSIP: 25253X207

Event date: 2025-09-30

Filing-level shares
4,958,823
Percent of class
9.6%
  • Richard Jacinto II

    Shares: 4,958,823 · Class: 9.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-272616
Form type
SCHEDULE 13G/A
Filer
DiaMedica Therapeutics Inc.
CIK
CIK 1401040
Filed
Nov 07, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub